Recently, Prof. WU Zhengyan from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, in collaboration with Prof. ZHANG Guilong from Binzhou Medical University, has developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.
2025
FDA Clears IND Application for CER-1236 in Advanced Solid Tumors
A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.
How midkine helps tumours evade immunotherapy
How midkine helps tumours evade immunotherapy
Mobile App Cuts Skin Cancer Referrals in Half, British Trial Shows
The Map My Mole app provides patients with a small lens attachment for their phones to capture high-quality images of concerning skin spots. These images are then uploaded for assessment by consultants.